Lilly and Novo Are Reportedly Near a Deal, Offering $149 GLP-1s in Return for Coverage in Medicare
Shares:
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
Fair warning: the rest of the week might be heavy on 340B. It’s a topic that is very hip, very 2025. ICER has decided that its next big research effort
If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.